Healthcare Marketing Has New Rules: What the NMC Guidelines Mean for Hospitals & Diagnostic Chains

What hospitals, diagnostic chains and healthcare professionals need to understand about the changing rules of healthcare communication

Healthcare marketing in India is undergoing an important shift. For years, hospitals, diagnostic centres and healthcare professionals have increasingly relied on digital platforms, social media, online campaigns, patient testimonials, influencer collaborations and promotional offers to build visibility and attract patients.

While these approaches have helped healthcare organisations expand their reach, they have also raised important questions about the boundaries between healthcare communication, commercial promotion and ethical medical practice.

The National Medical Commission (NMC), through its Guidelines on Ethical Advertising and Public Communication by Hospitals/Medical Institutions and Registered Medical Practitioners, has now sought to bring greater clarity to this area.

The public notice, dated October 6, 2026, makes the guidelines applicable with immediate effect. The stated objectives are clear: preserve the dignity of the medical profession, prevent commercialisation of healthcare, protect patients from misleading claims, and ensure that healthcare communication remains factual, transparent and ethical.

For healthcare organisations, this is more than a regulatory development. It calls for a reassessment of how marketing strategies are designed, how digital platforms are used and how institutional reputation is built. Synopsis of NMC Guidelines on Healthcare Marketing

1. Healthcare marketing is not prohibited, but its boundaries are changing

One of the important aspects of the new guidelines is that they do not prohibit all forms of public communication or institutional advertising.

Hospitals and medical institutions can disseminate factual, objective and verifiable information about their facilities, departments, infrastructure, diagnostic capabilities, services, emergency facilities, accreditation status, charges and other institutional information permitted by applicable law.

However, the distinction between providing information and soliciting patients becomes critical.

Communication must not create unnecessary demand for medical procedures, encourage avoidable investigations or treatments, or exploit patients' concerns and vulnerabilities.

For instance, communicating that a hospital has a particular speciality, diagnostic facility or emergency service is fundamentally different from claiming that it is the best hospital, has the highest success rate or delivers guaranteed outcomes.

The underlying principle is that healthcare communication should help patients make informed decisions rather than influence them through exaggerated claims or commercial persuasion.

2. Social media and digital marketing come under closer scrutiny

For many healthcare organisations, social media has become an integral part of marketing. Facebook, Instagram, LinkedIn, YouTube, WhatsApp and other digital platforms are routinely used for visibility, patient engagement and lead generation.

The new guidelines specifically recognise digital and social media communication as part of the advertising ecosystem.

They also clarify that the rules apply irrespective of whether the communication is published directly by a hospital or practitioner, or through a third-party agency, influencer or digital platform.

This has important implications for healthcare marketing teams.

Some commonly used promotional practices now require careful review, including:

• Promotional campaigns involving doctors and their professional achievements.

• Influencer collaborations designed to generate patient enquiries.

• Paid promotions and sponsored content.

• Patient testimonials and success stories used for commercial promotion.

• Promotional claims around treatment outcomes and clinical expertise.

• Paid rankings, ratings or online visibility arrangements intended to create an impression of professional superiority.

Engaging a marketing agency or influencer does not transfer the regulatory responsibility away from the healthcare institution or medical professional.

Healthcare organisations must therefore exercise greater control over the content published in their name and the communication strategies undertaken on their behalf.

3. Patient testimonials, success stories and outcome claims

Patient testimonials have traditionally been a popular marketing tool for hospitals and clinics. Videos of satisfied patients, treatment journeys, recovery stories and surgical outcomes are frequently used to establish credibility.

The new guidelines place significant restrictions on this practice.

Registered Medical Practitioners are not permitted to publish or use patient testimonials, photographs, clinical images or case histories for promotional purposes. They are also restricted from using before-and-after photographs, celebrity endorsements and success stories for commercial promotion.

Even where patient consent has been obtained, consent alone does not make otherwise prohibited promotional activity permissible.

The guidelines also discourage claims such as guaranteed cures, 100% success rates, miracle treatments and other statements that can create unrealistic expectations.

This is an important distinction for healthcare marketers. A patient education initiative that explains a disease, treatment process or general clinical information is different from using an individual patient's experience to solicit more patients.

The emphasis must move towards communicating clinical capabilities and factual institutional information rather than using individual patient outcomes as marketing material.

4. AI-generated content and healthcare advertising

Perhaps one of the more contemporary aspects of the guidelines is the explicit treatment of Artificial Intelligence.

AI-generated or AI-assisted promotional content intended to commercially promote a hospital, medical institution or registered medical practitioner is prohibited under the guidelines.

This includes synthetic or materially AI-altered content that could mislead patients about diagnoses, treatments, outcomes, professional qualifications or patient experiences.

The guidelines also address the use of patient information as inputs for AI systems, requiring compliance with applicable privacy, data protection and professional confidentiality obligations.

This has implications for healthcare organisations that are rapidly adopting AI for content creation, digital campaigns and marketing automation.

AI can undoubtedly support healthcare operations, research, information management and patient education. However, its use in promotional communication must remain within the boundaries prescribed by the NMC.

Healthcare organisations should review their existing AI-enabled marketing workflows rather than assume that technology-generated content is exempt from professional and regulatory standards.

5. Discounts, promotional offers and commercial inducements

Healthcare marketing has increasingly adopted practices borrowed from retail and consumer businesses.

Limited-period discounts, free consultations, cashback offers, referral incentives, bundled packages and promotional schemes are common in the market.

The new guidelines specifically restrict discounts, limited-period offers, coupons, gifts, cashback, referral benefits and similar inducements when these are likely to encourage unnecessary medical consultation, diagnostic investigation or treatment.

There is, however, an important distinction between a commercial inducement and transparent disclosure of charges.

Hospitals and medical institutions can communicate factual information about their charges, packages and fees, provided the disclosure is transparent and not misleading, and complies with applicable law.

For diagnostic chains, this is particularly relevant. Price transparency and clearly communicated test information remain important aspects of patient service. However, marketing strategies built around aggressive promotional offers, unnecessary testing or inducements need to be reassessed.

The focus should be on accessibility, service quality, operational efficiency and patient convenience rather than creating artificial demand through promotional pricing.

6. What can hospitals and diagnostic institutions communicate?

The guidelines do provide scope for institutional advertising within defined boundaries.

Hospitals and medical institutions may communicate factual information about:

• Their name, location and contact details.

• Departments, specialities and medical facilities.

• Diagnostic infrastructure and equipment.

• Emergency services and available facilities.

• Accreditation status and relevant certifications.

• Charges, packages and other permitted institutional information.

Such communication must remain objective, verifiable and free from misleading claims, patient solicitation or inducement.

This creates an opportunity for healthcare organisations to rethink their content strategy.

Instead of relying on promotional claims, institutions can build their communication around infrastructure, clinical capabilities, quality systems, technology, service availability and patient education.

For example, a diagnostic centre can communicate its NABL accreditation status, available testing facilities, sample collection network, operating hours and quality processes, wherever factually applicable.

Similarly, a hospital can provide information about its specialities, emergency infrastructure, facilities and services without making comparative superiority or guaranteed outcome claims.

The difference may appear subtle, but it is fundamental to ethical healthcare communication.

7. Public health education remains an important opportunity

The guidelines make an important distinction between public health education and promotional communication.

Medical practitioners may participate in health awareness programmes, public health campaigns, academic discussions, educational content and media interviews, provided these activities do not solicit patients or become promotional marketing.

Hospitals and institutions can also participate in public health awareness initiatives.

This is particularly relevant in areas such as preventive healthcare, diabetes awareness, cancer screening, cardiovascular health, women's health, occupational health and other important public health concerns.

Healthcare organisations should view this as an opportunity to build long-term credibility through knowledge sharing and community engagement.

An institution that consistently contributes meaningful health information can establish a stronger reputation than one that depends predominantly on advertisements and promotional campaigns.

The important condition is that educational communication must not become a disguised commercial solicitation exercise.

8. The business implications: Healthcare organisations need to rethink their marketing architecture

From a healthcare business perspective, the new guidelines should not be viewed merely as restrictions on marketing activities.

They present an opportunity to improve the quality and professionalism of healthcare communication.

Healthcare organisations will need to review their existing marketing practices, including:

1. Digital presence: Review websites, social media pages, paid campaigns and third-party promotional content for compliance.

2. Content strategy: Shift from exaggerated claims and promotional messaging towards factual information, patient education and institutional capabilities.

3. Marketing agency governance: Establish clear content approval processes and ensure that external agencies and influencers understand the applicable restrictions.

4. Brand positioning: Build institutional credibility through infrastructure, quality, clinical capabilities, transparency and service standards.

5. Internal accountability: Establish appropriate review mechanisms involving management, compliance and relevant medical professionals before publishing healthcare-related communication.

The guidelines also provide for graded corrective and disciplinary measures, ranging from warnings and mandatory ethics training to suspension or removal from the medical register in serious cases. The applicable consequences depend on the nature and severity of the violation.

For hospitals and medical institutions, violations may also attract action under the applicable clinical establishment and other relevant laws.

Therefore, compliance cannot remain the responsibility of the marketing department alone. It needs to become part of institutional governance.

Trust will become a more important differentiator than visibility

Healthcare is fundamentally different from most consumer businesses. Patients do not always possess the knowledge or ability to independently evaluate medical claims, treatment options or diagnostic recommendations. This places a greater responsibility on healthcare providers to communicate honestly and responsibly.

The new NMC guidelines reinforce this responsibility.

For hospitals, diagnostic chains and healthcare professionals, the challenge will be to maintain visibility, communicate capabilities and build institutional reputation without crossing ethical boundaries.

In my experience of working across the healthcare industry, sustainable growth is rarely built on advertising alone. It comes from consistent service quality, professional credibility, strong referral relationships, operational reliability and patient confidence.

The organisations that understand this distinction will be better positioned to adapt to the changing regulatory environment.

The future of healthcare marketing will not be about who makes the loudest claims or spends the most on digital promotion. It will be about who communicates with credibility, delivers on promises and earns the confidence of patients and the wider medical community with ethical communication. 

Disclaimer: This article is intended for general information and awareness purposes, particularly for healthcare leaders and marketers. It is based on the NMC Guidelines and should not be considered as legal advice or final word. Readers are advised to refer to the original NMC Guidelines for detailed provisions and any subsequent clarifications.